Monoclonal antibody
Identifiers |
---|
CAS Number | |
---|
ChemSpider | |
---|
UNII | |
---|
KEGG | |
---|
Chemical and physical data |
---|
Formula | C6374H9884N1696O2018S46 |
---|
Molar mass | 144037.80 g·mol−1 |
Trevogrumab (INN;[1] development code REGN1033) is a human monoclonal antibody designed for the treatment of muscle atrophy due to orthopedic disuse and sarcopenia.
This drug was developed by Regeneron Pharmaceuticals, Inc.[2]
References
- ^ World Health Organization (2015). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 113" (PDF). WHO Drug Information. 29 (2).
- ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Trevogrumab, American Medical Association.